Skip to main content

GOLDMAN SACHS GROUP INC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 886982 NEW YORK, NY

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$95,361,233
+$74,116,645 QoQ
Shares Held
5,619,401
+292.0% QoQ
Ownership
4.22%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 81% Shared 1% None 18%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. AUPH ranks #37 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $95,361,233 5,619,401
2026-03-31 $21,244,588 1,433,508
2025-12-31 $16,051,011 1,006,333
2025-09-30 $9,304,397 842,027
2025-06-30 $3,718,499 439,020
2025-03-31 $13,117,115 1,631,482
2024-12-31 $15,734,522 1,752,174
2024-09-30 $17,650,793 2,408,021
2024-06-30 $12,874,090 2,254,657
2024-03-31 $10,782,290 2,152,154
2023-12-31 $18,415,618 2,048,456
2023-09-30 $11,440,049 1,472,336
2023-06-30 $16,883,904 1,744,205
2023-03-31 $10,845,730 989,574
2022-12-31 $2,033,479 470,713
2022-09-30 $3,566,284 474,240
2022-06-30 $7,240,360 720,434
2022-03-31 $3,834,171 309,707
2021-12-31 $6,253,159 273,422
2021-09-30 $3,895,875 176,045
2021-06-30 $2,220,967 171,371
2021-03-31 $3,891,630 299,702
2020-12-31 $2,372,785 171,568
2020-09-30 $2,648,085 179,775
2020-06-30 $4,368,746 268,846
2020-03-31 $8,855,191 610,282